-+ 0.00%
-+ 0.00%
-+ 0.00%

Annovis Bio Secures FDA Agreement to Pool Buntanetap Safety Data From Alzheimer's, Parkinson's Trials

PUBT·11/20/2026 13:06:14
Annovis Bio Secures FDA Agreement to Pool Buntanetap Safety Data From Alzheimer's, Parkinson's Trials
  • Annovis Bio secured FDA agreement to pool Alzheimer’s and Parkinson’s trial safety data for buntanetap’s planned New Drug Application.
  • The safety package will combine four studies while the ongoing DUET-AD trial and Parkinson’s extension study continue.
  • More than 1,600 participants are expected to have received buntanetap by DUET-AD’s six-month data readout.
  • DUET-AD results are forthcoming; the application is planned following the readout.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611200800PRIMZONEFULLFEED9881905) on November 20, 2026, and is solely responsible for the information contained therein.